Paul Goddard Insider Profile
4 Followers
Paul Goddard, Director, Chairman at Heron Therapeutics, holds 225.93K shares in Heron Therapeutics (Ticker: HRTX), holds 0.00 shares in Corium (Ticker: CORI), holds 50.83K shares in XenoPort (Ticker: XNPT).
Paul Goddard's Trading History
| HRTXHeron Therapeutics | May 26, 2010 | Director, Chairman | Uninformative Buy | ― | $64.16K | |
| XNPTXenoPort | ― | ― | ― | $359.38K | ||
| CORICorium | ― | ― | ― | $0.00 |
You May Also Like
Paul Goddard insider profile FAQ
What stocks does Paul Goddard hold?
Paul Goddard holds: HRTX, CORI, XNPT stocks.
What is Paul Goddard's role in Heron Therapeutics?
Paul Goddard's role in Heron Therapeutics is Director, Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
